Skip to main content
🧬Peptide Protocol Wiki

Cardiovascular Peptides

Explore our collection of cardiovascular peptides with comprehensive research-backed information.

New to Peptides?

Other Categories

All PeptidesAnti-Aging & LongevityAnti-InflammatoryAnti-ObesityCognitive EnhancementCosmetic & Anti-WrinkleGrowth HormoneHealing & Tissue RepairHormonal HealthImmune SupportWeight Loss & MetabolismMitochondrial & Cellular EnergyMuscle & Bone HealthNeuropeptidesBrain & NeuroprotectionOtherPain ManagementPhysical PerformanceReproductive HealthSkin & HairSleep & RecoveryVascular & Cardiovascular
Anti-Aging & LongevityCardiovascular

Vesugen

Vesugen (KED, Lys-Glu-Asp, T-38) is an unapproved Khavinson tripeptide studied for vascular-endothelial and SIRT1-related effects. Reviews the PubMed evidence (incl. PMID 34071923) and the limits of the data.

View details →

Research Tools

Use our interactive tools to explore cardiovascular peptides further.

Dosing Calculator →Stack Compatibility →Evidence Explorer →Half-Life Chart →